Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1

Glaucoma is a group of optic neuropathies characterized by the progressive degeneration of retinal ganglion cells (RGCs) as well as their axons leading to irreversible loss of sight. Medical management of the intraocular pressure (IOP) still represents the gold standard in glaucoma therapy, which on...

Descripción completa

Detalles Bibliográficos
Autores principales: Fomo, Kristian Nzogang, Schmelter, Carsten, Atta, Joshua, Beutgen, Vanessa M., Schwarz, Rebecca, Perumal, Natarajan, Govind, Gokul, Speck, Thomas, Pfeiffer, Norbert, Grus, Franz H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613933/
https://www.ncbi.nlm.nih.gov/pubmed/36313990
http://dx.doi.org/10.3389/fmed.2022.993351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613933/
https://www.ncbi.nlm.nih.gov/pubmed/36313990
http://dx.doi.org/10.3389/fmed.2022.993351

Ejemplares similares